{"id":154759,"date":"2021-02-06T08:51:04","date_gmt":"2021-02-06T13:51:04","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/neoleukin-therapeutics-to-participate-in-guggenheim-healthcare-talks-2021-oncology-days\/"},"modified":"2024-08-18T11:43:02","modified_gmt":"2024-08-18T15:43:02","slug":"neoleukin-therapeutics-to-participate-in-guggenheim-healthcare-talks-2021-oncology-days","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/neoleukin-therapeutics-to-participate-in-guggenheim-healthcare-talks-2021-oncology-days.php","title":{"rendered":"Neoleukin Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days"},"content":{"rendered":"<p><![CDATA[SEATTLE, Feb.  05, 2021  (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., \u201cNeoleukin\u201d (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design\u00a0de novo\u00a0protein therapeutics, today announced that Jonathan Drachman, M.D., Chief Executive Officer, will participate in a fireside chat during the Guggenheim Healthcare Talks | 2021 Oncology Days on Friday, March 12, 2021 at 3 p.m. Eastern Time.]]><\/p>\n<p>Continued here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2021\/02\/05\/2170659\/0\/en\/Neoleukin-Therapeutics-to-Participate-in-Guggenheim-Healthcare-Talks-2021-Oncology-Days.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Neoleukin Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days\">Neoleukin Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Continued here: Neoleukin Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/neoleukin-therapeutics-to-participate-in-guggenheim-healthcare-talks-2021-oncology-days.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-154759","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/154759"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=154759"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/154759\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=154759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=154759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=154759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}